ENTITY

Medlab Clinical (MDC AU)

13
Analysis
Health CareAustralia
Medlab Clinical Limited operates as a nutritional early phase drug development company. The Company offers research and product development in the field of chronic kidney disease, obesity, depression, pain management, and muscular-skeletal health. Medlab Clinical develops bacteria based medicines.
more
Refresh
bullishMedlab Clinical
31 Oct 2022 16:16Issuer-paid

Medlab Clinical - Cash position supported by A$3.6m R&D grant

Medlab Clinical has released its unaudited cash flow report for Q123 and provided an update for the period. The company’s cash position was...

Share
bullishMedlab Clinical
20 Sep 2022 15:52Issuer-paid

Medlab Clinical - Observational trials to support development

Medlab Clinical has announced it has received ethics approval to conduct two new observational clinical trials in Australia for its lead...

Share
bullishMedlab Clinical
02 Sep 2022 16:32Issuer-paid

Medlab Clinical - FY23 a year of clinical development

As part of its transformation into a pureplay biotech, Medlab is preparing an IND submission for NanaBis and plans to begin clinical trials with...

Share
bullishMedlab Clinical
02 Aug 2022 19:32Issuer-paid

Medlab Clinical - FY22 cash flows within our expectations

Medlab Clinical has released its cash flow report for Q422 and the full FY22 period. Net cash outflow from operating activities in FY22 was A$9.0m,...

Share
bullishMedlab Clinical
14 Jul 2022 16:02Issuer-paid

Medlab Clinical - NanaBis – now with synthetic CBD and THC

Following the company’s transformation to a pureplay biotech, Medlab Clinical has focused on the development of key asset NanaBis, a 50:50 micellar...

Share
x